On July 6, Marvell Technology rose 3.71% overnight, trading at $255.84/share, with turnover of $7.7353 million. The stock rebounded after several consecutive trading sessions of significant pullback, supported by a broad semiconductor sector recovery and a major analyst upgrade.

On the news front, UBS published a research report substantially raising Marvell Technology's target price from $230 to $340, maintaining a Buy rating. The firm is bullish on Marvell's CXL (Compute Express Link) business growth prospects, projecting CXL-related revenue to reach approximately $10 billion in 2027 and $20 billion in 2028. UBS simultaneously raised total revenue forecasts to $168 billion and $239 billion for 2027 and 2028, respectively, driven by XPU connectivity and incremental CPU business contributions.

Within the Semiconductors sector, peers moved broadly higher, with Micron Technology up 7.52%, Intel up 3.61%, Advanced Micro Devices up 2.96%, Broadcom up 1.63%, and NVIDIA up 0.65%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)